Abstract:Background Traumatic brain injury (TBI) is among the leading causes of disability and has been strongly linked to Alzheimer's disease (AD), the most prevalent cause of dementia. Patients with a history of repeated TBI can present pathologies and symptoms similar to AD: Tau protein neurofibrillary tangles, Amyloid Beta Plaques, and chronic inflammation. We propose that TBI triggers pathological processes that underlie AD development and thereby accelerates AD's development and severity. Apolipoprotein E4 (ApoE4) protein has been thought to play a central role in several processes underlying AD development. ApoE4 is one of the biggest genetic risk factors for AD, which is also linked to worse short‐term and long‐term outcomes after TBI. However, how ApoE4 mechanistically affects the development of AD‐pathology after TBI has yet to be understood Method To explore this gap, we will use mice with humanized genes which develop AD like pathology with age (Late‐onset AD). The humanized genes include amyloid precursor protein (hAPP) and microtubule‐associated protein tau (hMAPT) ‐ precursors to amyloid beta plaques and neurofibrillary tangles, respectively ‐ in addition to two copies of apolipoprotein E4 (ApoE4) or the control ApoE3 allele. Half of these mice will experience three mild TBIs modeled after human concussions, while the other half will only be anesthetized. All mice will undergo behavioral testing to measure cognitive deficits and molecular analyses to characterize the timing and severity of AD pathology. Cognitive testing will be carried out using the rodent touchscreen Continuous Performance Test (rCPT), which are widely used with AD patients to test attentional processes. Result Preliminary results from rCPT before TBI, reveal no significant differences between genotypes and sex at 6‐month of age. Conclusion We aim to uncover how TBI interacts with ApoE4 protein to accelerate AD pathology at the molecular and behavioral levels. To maximize the clinical relevance of this project, we use mice with human genes implicated in AD, a clinically relevant noninvasive model of concussion, and touchscreen cognitive testing identical to touchscreen testing in humans. We aim to bridge the gap between animal models and clinical settings to identify future therapeutic targets for TBI and AD.

Astrocytic ApoE underlies maturation of hippocampal neurons and cognitive recovery after traumatic brain injury in mice

Next generation humanized mice to investigate how Traumatic Brain Injury interacts with ApoE4 genetic risk factor to accelerate dementia

APOE4 genetic polymorphism results in impaired recovery in a repeated mild traumatic brain injury model and treatment with Bryostatin-1 improves outcomes

Traumatic brain injury promotes neurogenesis at the cost of astrogliogenesis in the adult hippocampus of male mice

Repetitive head trauma and apoE4 induce chronic cerebrovascular alterations that impair tau elimination from the brain

Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology

ApoE4 expression disrupts tau uptake, trafficking, and clearance in astrocytes

Enhancing endocannabinoid signalling in astrocytes promotes recovery from traumatic brain injury

Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits

Elevated Hippocampal CD24 in Astrocytes Participates in Neural Regeneration Possibly Via Activating SHP2/ERK Pathway after Experimental Traumatic Brain Injury in Mice.

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis

APOE4 derived from astrocytes leads to blood–brain barrier impairment

Inhibitory roles of Apolipoprotein E Christchurch astrocytes in curbing tau propagation using human pluripotent stem cell-derived models

The Human ApoE4 Variant Reduces Functional Recovery and Neuronal Sprouting After Incomplete Spinal Cord Injury in Male Mice

Role of Apolipoprotein E in the Hippocampus and Its Impact following Ionizing Radiation Exposure

Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury

ApoE4 attenuates cortical neuronal activity in young behaving apoE4 rats

Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia

APOE4 Impairs Microglia ‐ Astrocyte Crosstalk in Alzheimer Disease

Neuron-targeted Knockout of APE1 Forces Premature Cognitive Impairment and Synaptic Dysfunction in Adult Mice

Deletion of MyD88 in astrocytes prevents β‐amyloid‐induced neuropathology in mice